In a landmark decision, the Centers for Medicare & Medicaid Services has announced it will now cover the use of FDA-approved dermal fillers for the treatment of HIV-associated facial lipoatrophy , severely hollowed cheeks and changes to the face's appearance resulting from HIV treatments.